$NROM
NOBLE ROMANS INC Stock $nrom

$nrom Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000165495424014260 Filed on November 13, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$3.880M
YoY Change		3.76%
Cost Of Revenue		$2.791M
YoY Change		6.95%
Gross Profit		$1.089M
YoY Change		-3.64%
Gross Profit Margin		28.06%
Selling, General & Admin		$566.3K
YoY Change		8.9%
% of Gross Profit		52.01%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		-$140.0K
YoY Change		-166.68%
% of Gross Profit		-12.86%
Operating Expenses		$2.791M
YoY Change		6.92%
Operating Profit		$416.6K
YoY Change		-18.94%
Interest Expense		$415.5K
YoY Change		15.61%
% of Operating Profit		99.74%
Other Income/Expense, Net		$192.2K
YoY Change
Pretax Income		$193.3K
YoY Change		25.11%
Income Tax		$0.00
% Of Pretax Income		0.0%
Net Earnings		$193.3K
YoY Change		25.11%
Net Earnings / Revenue		4.98%
Basic Earnings Per Share		$0.01
Diluted Earnings Per Share		$0.01
COMMON SHARES
Basic Shares Outstanding	22.22M shares	22.22M shares
Diluted Shares Outstanding		24.15M shares

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$551.5K
YoY Change		-1.52%
Cash & Equivalents		$551.5K
Short-Term Investments
Other Short-Term Assets		$162.5K
YoY Change		-76.46%
Inventory		$966.3K
Prepaid Expenses		$162.4K
Receivables		$782.5K
Other Receivables		$507.7K
Total Short-Term Assets		$2.970M
YoY Change		-15.5%
LONG-TERM ASSETS
Property, Plant & Equipment		$4.098M
YoY Change		-8.03%
Goodwill		$278.5K
YoY Change		0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$4.779M
YoY Change		13.24%
Total Long-Term Assets		$13.88M
YoY Change		-4.14%
TOTAL ASSETS
Total Short-Term Assets		$2.970M
Total Long-Term Assets		$13.88M
Total Assets		$16.85M
YoY Change		-6.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$458.8K
YoY Change		141.48%
Accrued Expenses		$852.4K
YoY Change		6.55%
Deferred Revenue
YoY Change
Short-Term Debt		$575.0K
YoY Change
Long-Term Debt Due		$6.756M
YoY Change		575.63%
Total Short-Term Liabilities		$9.181M
YoY Change		361.0%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change		-100.0%
Other Long-Term Liabilities		$5.295M
YoY Change		-7.6%
Total Long-Term Liabilities		$5.295M
YoY Change		-58.53%
TOTAL LIABILITIES
Total Short-Term Liabilities		$9.181M
Total Long-Term Liabilities		$5.295M
Total Liabilities		$14.48M
YoY Change		-1.92%
SHAREHOLDERS EQUITY
Retained Earnings		-$22.49M
YoY Change		4.08%
Common Stock		$24.86M
YoY Change		0.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$2.372M
YoY Change
Total Liabilities & Shareholders Equity		$16.85M
YoY Change		-6.36%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		$193.3K
YoY Change		25.11%
Depreciation, Depletion And Amortization		-$140.0K
YoY Change		-166.68%
Cash From Operating Activities		$23.54K
YoY Change		-96.68%
INVESTING ACTIVITIES
Capital Expenditures		$23.13K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$23.13K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-250.0K
YoY Change		-69.88%
NET CHANGE
Cash From Operating Activities		23.54K
Cash From Investing Activities		-23.13K
Cash From Financing Activities		-250.0K
Net Change In Cash		-249.6K
YoY Change		107.99%
FREE CASH FLOW
Cash From Operating Activities		$23.54K
Capital Expenditures		$23.13K
Free Cash Flow		$410.00
YoY Change		-99.94%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22215512	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
	nrom	Stock Dilutiondenominator StockDilutiondenominator	902941	shares
	nrom	Diluted Earnings Per Share Net Loss DilutedEarningsPerShareNetLoss	206820	usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22215512	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
	nrom	Stock Dilutiondenominator StockDilutiondenominator	115788	shares
	nrom	Diluted Earnings Per Share Net Loss DilutedEarningsPerShareNetLoss	1392736	usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2020Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0775	pure
CY2024Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.1311	pure
CY2023Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.1316	pure
CY2024Q3	nrom	Line Of Credit Principal LineOfCreditPrincipal	6958692	usd
CY2024Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	202425	usd
CY2024Q3	us-gaap	Line Of Credit LineOfCredit	6756267	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	540650	usd
CY2024Q3	us-gaap	Other Liabilities OtherLiabilities	538822	usd
CY2024Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1718000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	258000	usd
	nrom	Net Benefit Or Refund NetBenefitOrRefund	1460000	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	83000	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	157861	usd
CY2024Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	153074	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	27086	usd
CY2024Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	32339	usd
CY2023Q4	nrom	Equipment Inventory EquipmentInventory	780872	usd
CY2024Q3	nrom	Equipment Inventory EquipmentInventory	780872	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	965819	usd
	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	192538	usd
	nrom	Royalty And Feees Description RoyaltyAndFeeesDescription	after deferring initial fees of $180,000 and amortizing $164,538 of previously deferred fees and receiving $28,000 in transfer fees
	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	130596	usd
CY2024Q3	us-gaap	Deferred Income DeferredIncome	1563718	usd
CY2024Q3	us-gaap	Deferred Costs Current DeferredCostsCurrent	1403899	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2024Q3	nrom	Diluted Earnings Per Share Net Loss DilutedEarningsPerShareNetLoss	207689	usd
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2023Q3	nrom	Stock Dilutiondenominator StockDilutiondenominator	115778	shares
CY2023Q3	nrom	Diluted Earnings Per Share Net Loss DilutedEarningsPerShareNetLoss	168891	usd
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	24368453	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	23581300	shares
	dei	Entity Central Index Key EntityCentralIndexKey	0000709005
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.00
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.00
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22215512	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22215512	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22215512	shares
CY2022Q4	us-gaap	Deferred Income DeferredIncome	934036	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Entity File Number EntityFileNumber	0-11104
	dei	Entity Registrant Name EntityRegistrantName	NOBLE ROMAN’S, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	IN
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	35-1281154
	dei	Entity Address Address Line1 EntityAddressAddressLine1	6612 E
	dei	Entity Address Address Line2 EntityAddressAddressLine2	75th Street
	dei	Entity Address Address Line3 EntityAddressAddressLine3	Suite 450
	dei	Entity Address City Or Town EntityAddressCityOrTown	Indianapolis
	dei	Entity Address State Or Province EntityAddressStateOrProvince	IN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	46250
	dei	City Area Code CityAreaCode	317
	dei	Local Phone Number LocalPhoneNumber	634-3377
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	22215512	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	872335	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	551479	usd
CY2023Q4	nrom	Employee Retention Tax Credit Receivable EmployeeRetentionTaxCreditReceivable	507726	usd
CY2024Q3	nrom	Employee Retention Tax Credit Receivable EmployeeRetentionTaxCreditReceivable	507726	usd
CY2023Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	1169446	usd
CY2024Q3	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	782500	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	965819	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	966285	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	318195	usd
CY2024Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	162445	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	3833521	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	2970435	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	4386430	usd
CY2024Q3	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	4443018	usd
CY2023Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3130430	usd
CY2024Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3141101	usd
CY2023Q4	nrom	Leasehold Improvements LeaseholdImprovements	7516860	usd
CY2024Q3	nrom	Leasehold Improvements LeaseholdImprovements	7584119	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3196993	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3485627	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4319867	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4098492	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3374841	usd
CY2024Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3374841	usd
CY2023Q4	us-gaap	Deferred Costs DeferredCosts	1403299	usd
CY2024Q3	us-gaap	Deferred Costs DeferredCosts	1403899	usd
CY2023Q4	us-gaap	Goodwill Goodwill	278466	usd
CY2024Q3	us-gaap	Goodwill Goodwill	278466	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4930014	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4354294	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	339817	usd
CY2024Q3	us-gaap	Other Assets OtherAssets	367645	usd
CY2023Q4	us-gaap	Assets Assets	18479825	usd
CY2024Q3	us-gaap	Assets Assets	16848072	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1284210	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	458811	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	799165	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	852428	usd
CY2023Q4	nrom	Loan Payable Current LoanPayableCurrent	1000000	usd
CY2024Q3	nrom	Loan Payable Current LoanPayableCurrent	6756267	usd
CY2023Q4	us-gaap	Subordinated Debt SubordinatedDebt	0	usd
CY2024Q3	us-gaap	Subordinated Debt SubordinatedDebt	575000	usd
CY2023Q4	nrom	Warrant Liability Current WarrantLiabilityCurrent	540650	usd
CY2024Q3	nrom	Warrant Liability Current WarrantLiabilityCurrent	538822	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3624025	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	9181328	usd
CY2023Q4	nrom	Loan Payable Non Current LoanPayableNonCurrent	6133691	usd
CY2024Q3	nrom	Loan Payable Non Current LoanPayableNonCurrent	0	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	575000	usd
CY2024Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	0	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4378927	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3730787	usd
CY2023Q4	us-gaap	Deferred Revenue And Credits Noncurrent DeferredRevenueAndCreditsNoncurrent	1577299	usd
CY2024Q3	us-gaap	Deferred Revenue And Credits Noncurrent DeferredRevenueAndCreditsNoncurrent	1563718	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	12664917	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	5294505	usd
CY2023Q4	us-gaap	Liabilities Liabilities	16288942	usd
CY2024Q3	us-gaap	Liabilities Liabilities	14475833	usd
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22215512	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	24840126	usd
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	24857787	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22649243	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22485548	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	2190883	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	2372239	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18479825	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16848072	usd
CY2023Q3	nrom	Restaurant Revenue Company Owned Restaurants RestaurantRevenueCompanyOwnedRestaurants	2175219	usd
CY2024Q3	nrom	Restaurant Revenue Company Owned Restaurants RestaurantRevenueCompanyOwnedRestaurants	2195167	usd
	nrom	Restaurant Revenue Company Owned Restaurants RestaurantRevenueCompanyOwnedRestaurants	6639213	usd
	nrom	Restaurant Revenue Company Owned Restaurants RestaurantRevenueCompanyOwnedRestaurants	6413242	usd
CY2023Q3	nrom	Restaurant Revenue Company Owned Non Traditional RestaurantRevenueCompanyOwnedNonTraditional	247252	usd
CY2024Q3	nrom	Restaurant Revenue Company Owned Non Traditional RestaurantRevenueCompanyOwnedNonTraditional	218193	usd
	nrom	Restaurant Revenue Company Owned Non Traditional RestaurantRevenueCompanyOwnedNonTraditional	707217	usd
	nrom	Restaurant Revenue Company Owned Non Traditional RestaurantRevenueCompanyOwnedNonTraditional	693045	usd
CY2023Q3	nrom	Revenue Recognition Services Franchise RevenueRecognitionServicesFranchise	1310284	usd
CY2024Q3	nrom	Revenue Recognition Services Franchise RevenueRecognitionServicesFranchise	1437664	usd
	nrom	Revenue Recognition Services Franchise RevenueRecognitionServicesFranchise	3671160	usd
	nrom	Revenue Recognition Services Franchise RevenueRecognitionServicesFranchise	4298703	usd
CY2023Q3	us-gaap	Payment For Administrative Fees PaymentForAdministrativeFees	6657	usd
CY2024Q3	us-gaap	Payment For Administrative Fees PaymentForAdministrativeFees	29142	usd
	us-gaap	Payment For Administrative Fees PaymentForAdministrativeFees	22068	usd
	us-gaap	Payment For Administrative Fees PaymentForAdministrativeFees	45959	usd
CY2023Q3	us-gaap	Revenues Revenues	3739412	usd
CY2024Q3	us-gaap	Revenues Revenues	3880166	usd
	us-gaap	Revenues Revenues	11039658	usd
	us-gaap	Revenues Revenues	11450949	usd
CY2023Q3	nrom	Restaurant Expenses Company Owned Restaurants RestaurantExpensesCompanyOwnedRestaurants	1974635	usd
CY2024Q3	nrom	Restaurant Expenses Company Owned Restaurants RestaurantExpensesCompanyOwnedRestaurants	2021828	usd
	nrom	Restaurant Expenses Company Owned Restaurants RestaurantExpensesCompanyOwnedRestaurants	5914648	usd
	nrom	Restaurant Expenses Company Owned Restaurants RestaurantExpensesCompanyOwnedRestaurants	5831544	usd
CY2023Q3	nrom	Restaurant Expenses Company Owned Non Traditional RestaurantExpensesCompanyOwnedNonTraditional	240245	usd
CY2024Q3	nrom	Restaurant Expenses Company Owned Non Traditional RestaurantExpensesCompanyOwnedNonTraditional	269675	usd
	nrom	Restaurant Expenses Company Owned Non Traditional RestaurantExpensesCompanyOwnedNonTraditional	566225	usd
	nrom	Restaurant Expenses Company Owned Non Traditional RestaurantExpensesCompanyOwnedNonTraditional	730723	usd
CY2023Q3	nrom	Franchising Expenses Benefit FranchisingExpensesBenefit	395777	usd
CY2024Q3	nrom	Franchising Expenses Benefit FranchisingExpensesBenefit	499781	usd
	nrom	Franchising Expenses Benefit FranchisingExpensesBenefit	-36255	usd
	nrom	Franchising Expenses Benefit FranchisingExpensesBenefit	1450143	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	2610657	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	2791284	usd
	us-gaap	Operating Expenses OperatingExpenses	6444618	usd
	us-gaap	Operating Expenses OperatingExpenses	8012410	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	95517	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	96068	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	286550	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	288634	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	519291	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	566275	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1564433	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1713691	usd
CY2023Q3	nrom	Defense Against Activist Shareholder DefenseAgainstActivistShareholder	0	usd
CY2024Q3	nrom	Defense Against Activist Shareholder DefenseAgainstActivistShareholder	9916	usd
	nrom	Defense Against Activist Shareholder DefenseAgainstActivistShareholder	0	usd
	nrom	Defense Against Activist Shareholder DefenseAgainstActivistShareholder	29458	usd
CY2023Q3	us-gaap	Costs And Expenses CostsAndExpenses	3225465	usd
CY2024Q3	us-gaap	Costs And Expenses CostsAndExpenses	3463543	usd
	us-gaap	Costs And Expenses CostsAndExpenses	8295602	usd
	us-gaap	Costs And Expenses CostsAndExpenses	10044193	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	513947	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	416623	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	2744056	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1406756	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	359431	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	415524	usd
	us-gaap	Interest Expense InterestExpense	1121505	usd
	us-gaap	Interest Expense InterestExpense	1244889	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2024Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-192215	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1828	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	154516	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	193314	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1622551	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	163695	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	274190	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	154516	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	193314	usd
	us-gaap	Profit Loss ProfitLoss	1348361	usd
	us-gaap	Profit Loss ProfitLoss	163695	usd
CY2023Q3	nrom	Net Income Before Income Tax Basic NetIncomeBeforeIncomeTaxBasic	0.01
CY2024Q3	nrom	Net Income Before Income Tax Basic NetIncomeBeforeIncomeTaxBasic	0.01
	nrom	Net Income Before Income Tax Basic NetIncomeBeforeIncomeTaxBasic	0.07
	nrom	Net Income Before Income Tax Basic NetIncomeBeforeIncomeTaxBasic	0.01
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22215512	shares
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22215512	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22215512	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22215512	shares
CY2023Q3	nrom	Net Income Before Income Tax Diluted NetIncomeBeforeIncomeTaxDiluted	0.01
CY2024Q3	nrom	Net Income Before Income Tax Diluted NetIncomeBeforeIncomeTaxDiluted	0.01
	nrom	Net Income Before Income Tax Diluted NetIncomeBeforeIncomeTaxDiluted	0.07
	nrom	Net Income Before Income Tax Diluted NetIncomeBeforeIncomeTaxDiluted	0.01
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23581300	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24149723	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23581300	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24368453	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	2190883	usd
	us-gaap	Net Income Loss NetIncomeLoss	163695	usd
	nrom	Amortization Of Value Of Employee Stock Options AmortizationOfValueOfEmployeeStockOptions	17661	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	2372239	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	2167247	usd
CY2024Q3	nrom	Amortization Of Value Of Employee Stock Options AmortizationOfValueOfEmployeeStockOptions	11678	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	193314	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	2372239	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	710209	usd
	us-gaap	Net Income Loss NetIncomeLoss	1348361	usd
	nrom	Amortization Of Value Of Employee Stock Options AmortizationOfValueOfEmployeeStockOptions	17869	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	2076439	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1916845	usd
CY2023Q3	nrom	Amortization Of Value Of Employee Stock Options AmortizationOfValueOfEmployeeStockOptions	5080	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	154514	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	2076439	usd
	us-gaap	Net Income Loss NetIncomeLoss	1348361	usd
	us-gaap	Net Income Loss NetIncomeLoss	163695	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1828	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	286549	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	288634	usd
	nrom	Interest Paid In Kind InterestPaidInKind	192758	usd
	nrom	Interest Paid In Kind InterestPaidInKind	195351	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	17869	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	17661	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	137999	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	177225	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-845902	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-833485	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	274190	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
	nrom	Increase Decrease In Employee Retention Tax Credit IncreaseDecreaseInEmployeeRetentionTaxCredit	507726	usd
	nrom	Increase Decrease In Employee Retention Tax Credit IncreaseDecreaseInEmployeeRetentionTaxCredit	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-14284	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-386946	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-55105	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	466	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	266495	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-155750	usd
	nrom	Increase Decrease In Deferred Contract Income Net Of Deferred Contract Cost IncreaseDecreaseInDeferredContractIncomeNetOfDeferredContractCost	-14181	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	45746	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	27828	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-458143	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-825399	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-838492	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-852642	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1056415	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	496403	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	29781	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	67259	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-29781	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-67259	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	50000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
	us-gaap	Payments Of Loan Costs PaymentsOfLoanCosts	1198510	usd
	us-gaap	Payments Of Loan Costs PaymentsOfLoanCosts	750000	usd
	nrom	Payments Of Lease Liabilities PaymentsOfLeaseLiabilities	0	usd
	nrom	Payments Of Lease Liabilities PaymentsOfLeaseLiabilities	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1248510	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-750000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-221876	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-320856	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	785522	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	872335	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	563646	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	551479	usd
	us-gaap	Interest Paid InterestPaid	793692	usd
	us-gaap	Interest Paid InterestPaid	901357	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1718000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	966285	usd
CY2023Q4	us-gaap	Deferred Income DeferredIncome	1577299	usd
CY2023Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	1403299	usd
CY2022Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	934036	usd
CY2024Q3	nrom	Net Income Losses NetIncomeLosses	193314	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22215512	shares
CY2024Q3	nrom	Stock Dilutiondenominator StockDilutiondenominator	684211	shares
CY2024Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	24149723	shares
CY2023Q3	nrom	Net Income Losses NetIncomeLosses	154516	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22215512	shares
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	23581290	shares
	nrom	Net Income Losses NetIncomeLosses	163695	usd
	nrom	Net Income Losses NetIncomeLosses	1348361	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.43	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y4M6D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0366	pure
CY2024Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0	pure
CY2023Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0	pure
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	274190	usd
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.168	pure
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	984334	shares

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001654954-24-014260-index-headers.html	Edgar Link	pending
0001654954-24-014260-index.html	Edgar Link	pending
0001654954-24-014260.txt	Edgar Link	pending
0001654954-24-014260-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nrom-20240930.xsd	Edgar Link	pending
nrom_10q.htm	Edgar Link	pending
nrom_ex311.htm	Edgar Link	pending
nrom_ex312.htm	Edgar Link	pending
nrom_ex321.htm	Edgar Link	pending
nrom_ex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
nrom-20240930_def.xml	Edgar Link	unprocessable
nrom-20240930_lab.xml	Edgar Link	unprocessable
nrom-20240930_pre.xml	Edgar Link	unprocessable
nrom_10q_htm.xml	Edgar Link	completed
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
nrom-20240930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NROM
NOBLE ROMANS INC Stock $nrom

2024 Q4 Form 10-Q Financial Statement

#000165495424014260 Filed on November 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NROM NOBLE ROMANS INC Stock $nrom

2024 Q4 Form 10-Q Financial Statement

#000165495424014260 Filed on November 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NROM
NOBLE ROMANS INC Stock $nrom